|
CH637297A5
(fr)
|
1978-12-05 |
1983-07-29 |
Nestle Sa |
Microbille comprenant un microorganisme et son procede de fabrication.
|
|
JPS5846293B2
(ja)
*
|
1980-04-08 |
1983-10-15 |
明治製菓株式会社 |
ビフイズス菌含有錠菓及びその製造法
|
|
CA1333564C
(en)
*
|
1988-08-02 |
1994-12-20 |
Thomas Julius Borody |
Treatment of gastro-intestinal disorders
|
|
US5443826A
(en)
*
|
1988-08-02 |
1995-08-22 |
Borody; Thomas J. |
Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
|
|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
|
FR2903574B1
(fr)
|
2006-07-13 |
2008-09-05 |
Gervais Danone Sa |
Granules de cysteine et leurs utilisations a titre d'activateurs de croissance de bifidobacterium animalis lactis.
|
|
CA2807242C
(en)
|
2010-08-04 |
2017-05-02 |
Thomas Julius Borody |
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
|
|
BR112013022927A2
(pt)
|
2011-03-09 |
2016-12-06 |
Univ Minnesota |
composição, métodos para substituir ou suplementar ou modificar uma microbiota do cólon de um sujeito, e para tratar um sujeito, e, uso de uma composição
|
|
WO2013176774A1
(en)
|
2012-05-25 |
2013-11-28 |
Arizona Board Of Regents |
Microbiome markers and therapies for autism spectrum disorders
|
|
KR20180026376A
(ko)
|
2015-05-14 |
2018-03-12 |
크레스토보 홀딩스 엘엘씨 |
대변 균무리 이식용 조성물, 및 이의 제조 및 사용 방법, 및 이의 전달을 위한 장치
|
|
HUE058209T2
(hu)
|
2015-05-22 |
2022-07-28 |
Univ Arizona State |
Módszerek az autizmus spektrum zavar és azzal összefüggõ tünetek kezelésére
|
|
US20170360848A1
(en)
|
2016-06-15 |
2017-12-21 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods for treating autism spectrum disorder and associated symptoms
|
|
US10849936B2
(en)
|
2016-07-01 |
2020-12-01 |
Regents Of The University Of Minnesota |
Compositions and methods for C. difficile treatment
|
|
US20180036352A1
(en)
|
2016-08-03 |
2018-02-08 |
Crestovo Holdings Llc |
Methods for treating ulcerative colitis
|
|
US10092601B2
(en)
|
2016-10-11 |
2018-10-09 |
Crestovo Holdings Llc |
Compositions and methods for treating multiple sclerosis and related disorders
|
|
WO2018071536A1
(en)
|
2016-10-11 |
2018-04-19 |
Crestovo Holdings Llc |
Compositions and methods for treating primary sclerosing cholangitis and related disorders
|
|
US11026978B2
(en)
|
2016-10-11 |
2021-06-08 |
Finch Therapeutics Holdings Llc |
Compositions and methods for treating multiple sclerosis and related disorders
|
|
WO2018187467A1
(en)
|
2017-04-05 |
2018-10-11 |
Crestovo Holdings Llc |
Compositions and methods for treating parkinson's disease (pd) and related disorders
|
|
US11040073B2
(en)
|
2017-04-05 |
2021-06-22 |
Finch Therapeutics Holdings Llc |
Compositions and methods for treating diverticulitis and related disorders
|
|
EP3630190B1
(en)
|
2017-05-26 |
2024-02-21 |
Finch Therapeutics Holdings LLC |
Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
|
|
AU2018313766A1
(en)
|
2017-08-07 |
2020-02-20 |
Finch Therapeutics, Inc. |
Compositions and methods for maintaining and restoring a healthy gut barrier
|
|
EP3524051A1
(en)
*
|
2018-02-12 |
2019-08-14 |
DuPont Nutrition Biosciences ApS |
Matricial microencapsulation compositions
|
|
US11166990B2
(en)
|
2018-07-13 |
2021-11-09 |
Finch Therapeutics Holdings Llc |
Methods and compositions for treating ulcerative colitis
|
|
WO2020069280A1
(en)
|
2018-09-27 |
2020-04-02 |
Crestovo Holdings Llc |
Compositions and methods for treating epilepsy and related disorders
|
|
CA3147629A1
(en)
|
2019-07-19 |
2021-01-28 |
Finch Therapeutics Holdings Llc. |
Methods and products for treatment of gastrointestinal disorders
|
|
CN115317458B
(zh)
*
|
2022-09-14 |
2023-10-31 |
安徽金太阳生化药业有限公司 |
一种土霉素片的制备工艺
|